Cologuard Plus™ test raises the performance bar with sensitivities of 95% for colorectal cancer and 43% for advanced precancerous lesions at 94% specificity Cologuard Plus test will minimize ...
Studies show higher completion rates for mt-sDNA testing and the positive impact of patient navigation in expanding access to underserved and older populations “Exact Sciences’ research at ACG 2025 ...
North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...
The Health Care Service Corporation and Florida Blue updated their policies to cover Exact Sciences’ Cologuard. 2. HCSC’s subsidiaries include Blue Cross and Blue Shield plans in Illinois, Texas, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback